Broad Repertoire of the CD4+ Th Cell Response in Spontaneously Controlled Hepatitis C Virus Infection Includes Dominant and Highly Promiscuous Epitopes1

A vigorous hepatitis C virus (HCV)-specific Th cell response is regarded as essential to the immunological control of HCV viremia. The aim of this study was to comprehensively define the breadth and specificity of dominant HCV-specific CD4+ T cell epitopes in large cohorts of subjects with chronic and spontaneously resolved HCV viremia. Following in vitro stimulation of PBMC, HCV-specific cell cultures from each subject were screened with an overlapping panel of synthetic 20-mer peptides spanning the entire HCV polyprotein. Of 22 subjects who spontaneously controlled HCV viremia, all recognized at least one of a group of six epitopes situated within the nonstructural (NS) proteins NS3, NS4, and NS5, each of which was detected by >30% of subjects, but most subjects recognized additional, more heterogeneous specificities. In contrast, none of the most frequently targeted epitopes was detected by >5% of persons with chronic infection. The most frequently recognized peptides showed promiscuous binding to multiple HLA-DR molecules in in vitro binding assays and were restricted by different HLA-DR molecules in functional assays in different persons. These data demonstrate that predominant CD4+ T cell epitopes in persons with resolved HCV infection are preferentially located in the nonstructural proteins and are immunogenic in the context of multiple class II molecules. This comprehensive characterization of CD4+ T cell epitopes in resolved HCV infection provides important information to facilitate studies of immunopathogenesis and HCV vaccine design and evaluation.

[1]  Karina Yusim,et al.  The Los Alamos hepatitis C sequence database , 2005, Bioinform..

[2]  P. Simmonds,et al.  Genetic diversity and evolution of hepatitis C virus--15 years on. , 2004, The Journal of general virology.

[3]  C. Walker,et al.  Cell-mediated immunity and the outcome of hepatitis C virus infection. , 2004, Annual review of microbiology.

[4]  J. Berzofsky,et al.  Progress on new vaccine strategies against chronic viral infections. , 2004, The Journal of clinical investigation.

[5]  P. Klenerman,et al.  Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA‐DR11 restricted epitopes , 2004, Journal of viral hepatitis.

[6]  P. Klenerman,et al.  Ex Vivo Phenotype and Frequency of Influenza Virus-Specific CD4 Memory T Cells , 2004, Journal of Virology.

[7]  E. Rosenberg,et al.  Comprehensive Analysis of Human Immunodeficiency Virus Type 1-Specific CD4 Responses Reveals Marked Immunodominance of gag and nef and the Presence of Broadly Recognized Peptides , 2004, Journal of Virology.

[8]  G. Nepom,et al.  MHC Class II tetramers and the pursuit of antigen-specific T cells: define, deviate, delete. , 2004, Clinical immunology.

[9]  J. Sidney,et al.  Conserved Hierarchy of Helper T Cell Responses in a Chimpanzee during Primary and Secondary Hepatitis C Virus Infections 1 , 2004, The Journal of Immunology.

[10]  B. Walker,et al.  Progress in Defining CD4 Helper Cell Responses in Chronic Viral Infections , 2003, The Journal of experimental medicine.

[11]  Charles M. Rice,et al.  HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help , 2003, Science.

[12]  B. Walker,et al.  Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. , 2003, The Journal of clinical investigation.

[13]  A. Sette,et al.  Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. , 2003, Current opinion in immunology.

[14]  N. Gruener,et al.  Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. , 2003, Gastroenterology.

[15]  E. Borowski,et al.  The proteins of the Hepatitis C virus: Their features and interactions with intracellular protein phosphorylation , 2003, Archives of Virology.

[16]  R. Ahmed,et al.  CD8 T Cells Remember with a Little Help , 2003, Science.

[17]  B. Walker,et al.  Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection , 2002, Journal of Virology.

[18]  E. Robinson,et al.  Recognition of core and flanking amino acids of MHC class II‐bound peptides by the T cell receptor , 2002, European journal of immunology.

[19]  Daniel C Douek,et al.  References Subscriptions Permissions Email Alerts Direct Ex Vivo Analysis of Human CD4+ Memory T Cell Activation Requirements at the Single Clonotype Level , 2013 .

[20]  B. Walker,et al.  Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities , 2002, Journal of Virology.

[21]  I. W. Cheney,et al.  Mutations in NS5B polymerase of hepatitis C virus: impacts on in vitro enzymatic activity and viral RNA replication in the subgenomic replicon cell culture. , 2002, Virology.

[22]  John Sidney,et al.  A Rational Strategy to Design Multiepitope Immunogens Based on Multiple Th Lymphocyte Epitopes1 , 2002, The Journal of Immunology.

[23]  E. Rosenberg,et al.  Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses , 2002, Journal of Virology.

[24]  H. Reijonen,et al.  HLA class II tetramers: tools for direct analysis of antigen-specific CD4+ T cells. , 2002, Arthritis and rheumatism.

[25]  Gajendra P. S. Raghava,et al.  ProPred: prediction of HLA-DR binding sites , 2001, Bioinform..

[26]  F. Chisari,et al.  Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection , 2001, The Journal of experimental medicine.

[27]  Andrew W. Liu,et al.  Rapid epitope identification from complex class-II-restricted T-cell antigens. , 2001, Trends in immunology.

[28]  B. Walker,et al.  Hepatitis C virus infection. , 2001, The New England journal of medicine.

[29]  Andrew W. Liu,et al.  Tetramer-Guided Epitope Mapping: Rapid Identification and Characterization of Immunodominant CD4+ T Cell Epitopes from Complex Antigens1 , 2001, The Journal of Immunology.

[30]  John Sidney,et al.  Identification and Antigenicity of Broadly Cross-Reactive and Conserved Human Immunodeficiency Virus Type 1-Derived Helper T-Lymphocyte Epitopes , 2001, Journal of Virology.

[31]  Y. Shirota,et al.  Mutational analysis of the structure and functions of hepatitis C virus RNA–dependent RNA polymerase , 2001, Hepatology.

[32]  E. Rosenberg,et al.  Rapid Definition of Five Novel HLA-A∗3002-Restricted Human Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Epitopes by Elispot and Intracellular Cytokine Staining Assays , 2001, Journal of Virology.

[33]  F. Chisari,et al.  Differential CD4+ and CD8+ T‐cell responsiveness in hepatitis C virus infection , 2001, Hepatology.

[34]  John Sidney,et al.  HLA-DR-Promiscuous T Cell Epitopes from Plasmodium falciparum Pre-Erythrocytic-Stage Antigens Restricted by Multiple HLA Class II Alleles1 2 , 2000, The Journal of Immunology.

[35]  B. Walker,et al.  Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.

[36]  J. Gill,et al.  Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection , 2000, Immunological reviews.

[37]  H. Rammensee,et al.  SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.

[38]  Alessandro Sette,et al.  Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development , 1999, Hepatology.

[39]  T. Santantonio,et al.  Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. , 1999, Gastroenterology.

[40]  J Cohen,et al.  The Scientific Challenge of Hepatitis C , 1999, Science.

[41]  P Parham,et al.  Analysis of a successful immune response against hepatitis C virus. , 1999, Immunity.

[42]  B. Walker,et al.  Improved CD4 lymphocyte outgrowth in response to effective antiretroviral therapy. , 1999, The Journal of infectious diseases.

[43]  Spyros A. Kalams,et al.  The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses , 1998, The Journal of experimental medicine.

[44]  M F del Guercio,et al.  Several common HLA-DR types share largely overlapping peptide binding repertoires. , 1998, Journal of immunology.

[45]  M. Houghton,et al.  Recurrence of hepatitis C virus after loss of virus specific CD4+ T cell response in acute hepatitis C , 1998 .

[46]  E. Rosenberg,et al.  Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. , 1997, Science.

[47]  A Sette,et al.  Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection , 1997, Journal of virology.

[48]  R W Chesnut,et al.  Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. , 1997, Immunity.

[49]  R M Zinkernagel,et al.  A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  P. Doherty,et al.  Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells , 1996, The Journal of experimental medicine.

[51]  M. Massari,et al.  Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. , 1996, The Journal of clinical investigation.

[52]  P. Doherty,et al.  Progressive Loss of Cd8 + T Cell-mediated Control of a ~/-herpesvirus in the Absence of Cd4 + T Cells , 1996 .

[53]  M. Barnardo,et al.  Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). , 1995, Tissue antigens.

[54]  T. Santantonio,et al.  Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection , 1995, The Lancet.

[55]  M. Bunce,et al.  Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP). , 1995, Tissue antigens.

[56]  R. Ahmed,et al.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection , 1994, Journal of virology.

[57]  R. Zinkernagel,et al.  Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice , 1994, Journal of virology.

[58]  P. Parham,et al.  Peptide binding to major histocompatibility complex molecules. , 1993, Annual review of cell biology.

[59]  Matthew J. Brauer,et al.  Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. , 1991, Virology.

[60]  A. Weiner,et al.  Sequence variation in hepatitis C viral isolates. , 1991, Journal of hepatology.